Diffuse large B-cell lymphoma trials in Costa Rica

1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Active, not recruiting
  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Where

  San José, Santa Ana

  Age

  18 years and over

  People

  290 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05139017 · EU 2022-502646-27-00